Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum
Crossref DOI link: https://doi.org/10.1007/s00436-017-5487-x
Published Online: 2017-07-17
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Böhm, Claudia
Petry, Gabriele
Schmidt, Holger
Raue, Katharina
Barthel, Franziska
Schaper, Roland